The National Academy of Medicine (NAM) has elected Allan I. Levey, MD, PhD, and Robert F. Breiman, MD, to its 2017 class of leading health scientists and international members.
Levey is a neurologist and neuroscientist internationally recognized for his work in neurodegenerative disease. He is professor and chair of the Department of Neurology at Emory University School of Medicine, the Goizueta Foundation and Betty Gage Holland Endowed Chair for Alzheimer’s Disease Research, and director of the NIH-funded Emory Alzheimer’s Disease Research Center.
Breiman is director of the Emory Global Health Institute and professor in Emory’s Rollins School of Public Health. An infectious disease epidemiologist, he has led research programs in a variety of urban and rural surveillance systems, and is former director of the Kenya office of the US Centers for Disease Control and Prevention, the CDC’s largest overseas field operation.
Membership in the NAM, formerly the Institute of Medicine, is considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstanding professional achievements and commitment to service. Current active members elect new members from among candidates nominated for their accomplishments and contributions to the advancement of the medical sciences, health care and public health.
